Medline Inc.
MDLN- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0002046386
In the last 90 days, Medline Inc. insiders filed 0 open-market purchases and 3 sales; 408 institutions reported holding it in 13F filings for Q2 2026, worth $29.7B in total; 3 superinvestors hold it, including Lone Pine Capital and Viking Global Investors.
Superinvestors holding MDLN, Q2 2026
3 superinvestors report holding Medline Inc. on Form 13F, worth $1.08B in total. Weight is Medline Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Lone Pine CapitalStephen Mandel | 5.1% | 20,968,367 | $827.0M | Added+77.9% |
| Viking Global InvestorsAndreas Halvorsen | 0.5% | 4,841,080 | $190.9M | Reduced−57.7% |
| Soros Fund ManagementGeorge Soros | 0.8% | 1,638,244 | $64.6M | Added+27.3% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of MDLN each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
3 superinvestors holding at quarter end
- Added
- Lone Pine Capital (+77.9%), Soros Fund Management (+27.3%)
- Reduced
- Viking Global Investors (−57.7%)
- Sold out
- Maverick Capital
Q1 2026
4 superinvestors holding at quarter end
- Added
- Lone Pine Capital (+0.6%), Viking Global Investors (+64.3%)
- Reduced
- Soros Fund Management (−18.6%)
- Sold out
- D1 Capital Partners
Q4 2025
5 superinvestors holding at quarter end